Cargando…

Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States

BACKGROUND: Polypharmacy continues to be a topic of concern among older adults and puts patients at increased risk of potential drug-drug interactions (DDIs) and negative health outcomes. The objective of this study was to assess the prevalence of polypharmacy among older adults with cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheikh-Taha, Marwan, Asmar, Myriam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028718/ https://www.ncbi.nlm.nih.gov/pubmed/33827442 http://dx.doi.org/10.1186/s12877-021-02183-0

Ejemplares similares

Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review
por: Rodrigues, Maria Cristina Soares, et al.
Publicado: (2016)

The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan
por: Nusair, Mohammad B., et al.
Publicado: (2020)

Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
por: Chen, Zhaoyan, et al.
Publicado: (2023)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
por: Bachmann, Paula, et al.
Publicado: (2022)

Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment
por: Ramsdale, Erika, et al.
Publicado: (2022)

Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States
por: Oktora, Monika P., et al.
Publicado: (2019)

Rising CNS Polypharmacy Among Older Adults in the United States
por: Maust, Donovan
Publicado: (2020)

Polypharmacy and Potential Drug–Drug Interactions in Home-Dwelling Older People – A Cross-Sectional Study
por: Hermann, Monica, et al.
Publicado: (2021)

Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
por: Dookeeram, Darren, et al.
Publicado: (2017)

Polypharmacy and potential drug–drug interactions among Greenland’s care home residents
por: Albertsen, Nadja, et al.
Publicado: (2022)

Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
por: Kilit, Türkan Paşalı, et al.
Publicado: (2022)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
por: Krečak, Ivan, et al.
Publicado: (2023)

Severe potential drug-drug interactions in older adults with dementia and associated factors
por: Bogetti-Salazar, Michele, et al.
Publicado: (2016)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
por: Papotti, Bianca, et al.
Publicado: (2021)

Targeting continuity of care and polypharmacy to reduce drug–drug interaction
por: Weng, Yi-An, et al.
Publicado: (2020)

Polypharmacy and potential drug–drug interactions for people with HIV in the UK from the Climate‐HIV database
por: Okoli, C, et al.
Publicado: (2020)

Prevalence of polypharmacy and risk of potential drug-drug interactions among hospitalized patients with emphasis on the pharmacokinetics
por: Georgiev, Kaloyan D., et al.
Publicado: (2022)

Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA
por: Sheikh-Taha, Marwan, et al.
Publicado: (2017)

Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life
por: Farooq, Juveriya, et al.
Publicado: (2023)

Prescribed Versus Taken Polypharmacy and Drug–Drug Interactions in Older Cardiovascular Patients during the COVID-19 Pandemic: Observational Cross-Sectional Analytical Study
por: Anfinogenova, Nina D., et al.
Publicado: (2023)

Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016
por: Young, Eric H., et al.
Publicado: (2021)

Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
por: Courlet, Perrine, et al.
Publicado: (2019)

The effect of polypharmacy on healthcare services utilization in older adults with comorbidities: a retrospective cohort study
por: Doumat, George, et al.
Publicado: (2023)

Prescription Advice Based on Data of Drug-Drug-Gene Interaction of Patients with Polypharmacy
por: Salamone, Sandro, et al.
Publicado: (2022)

Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy
por: Al Rihani, Sweilem B., et al.
Publicado: (2020)

Hydroxychloroquine and Potential Drug Interactions in Older Adults
por: Velasco-González, Verónica, et al.
Publicado: (2020)

Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study
por: Alqahtani, Bader
Publicado: (2023)

Potential for Drug Interactions and Polypharmacy From Treatment of COVID-19 in Long-Term Care
por: Blaszczyk, Amie Taggart, et al.
Publicado: (2022)

POLYPHARMACY VERSUS DRUG COMBINATIONS
por: Agarwal, A.K.
Publicado: (1991)

Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia
por: Assefa, Yelbeneh Abayneh, et al.
Publicado: (2020)

Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia
por: Adem, Limi, et al.
Publicado: (2022)

Fat–Fit Patterns, Drug Consumption, and Polypharmacy in Older Adults: The EXERNET Multi-Center Study
por: Navarrete-Villanueva, David, et al.
Publicado: (2021)

Drug storage, polypharmacy and frailty syndrome in older people: an observational study
por: Tabué-Téguo, Maturin, et al.
Publicado: (2023)

The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
por: Guthrie, Bruce, et al.
Publicado: (2015)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Polypharmacy in Older Adults with Alzheimer’s Disease
por: Esumi, Satoru, et al.
Publicado: (2022)

Regional variations in excessive polypharmacy and potentially inappropriate drug use among older adults in Sweden: Trends from 2006 to 2020
por: Wastesson, Jonas W., et al.
Publicado: (2023)

Prevalence and factors associated with polypharmacy and potential drug interactions in adults in Manaus, Amazonas state, Brazil: a cross-sectional population-based study, 2019
por: Tiguman, Gustavo Magno Baldin, et al.
Publicado: (2022)

Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region
por: Burato, Sofia, et al.
Publicado: (2021)

Use of over the counter products in older cardiovascular patients admitted to a tertiary care center in USA
por: Sheikh-Taha, Marwan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h4bjce6n7f3ap5plo98rour0v4